1 Feb, 2022 @ 13:30
1 min read

Go ahead for final phase clinical trials of Spain’s own COVID-19 vaccine

Last phase starting in key clinical trials for Spain's own COVID-19 vaccine
Cordon Press image

SPAIN’S first domestically-made COVID-19 vaccine produced by Hipra is to start its final phase of clinical trials.

Approval was given by the Spanish Agency for Medicines and Health Products(AEMPS) on Tuesday.

It is the first COVID-19 vaccine to be created and manufactured in Spain.

The first tests produced good results in terms of safety and efficacy, and the vaccine is said to provide ‘good protection’ against the Omicron variant.

3,000 volunteers from 20 Spanish hospitals as well as centres in Italy and Portugal will take part in the phase III trial.

Phase II trials in November involved testing on 1,000 volunteers in ten hospitals in Spain.

If it is a success, then the Hipra vaccine could start to be used in a few months.

Subject to regulatory approval from the European Medicines Agency, Hipra anticipates being able to produce 600 million doses this year and double that number in 2023.

The first shots might be available by June this year.

Science Minister, Diana Morant, said: “This advance in research is a historic milestone for Spain.”

“It is something that is going to help both us and the rest of the world,” she added.


Lgb Homphobia Unsplash
Previous Story

Task force set up to tackle hate crime in the schools and streets of Spain’s Costa Blanca South

Benidorm and Costa Blanca hotels in Spain report 'tourism disaster' in 2021 due to COVID-19 pandemic
Next Story

Benidorm and Costa Blanca hotel association in Spain brands 2021 as a ‘tourism disaster’

Latest from Coronavirus

Go toTop

More From The Olive Press